Navigation Links
Perry Baromedical Announces New Cutting Edge Technology With Patient Data Capture Capability
Date:12/14/2009

RIVIERA BEACH, Fla., Dec. 14 /PRNewswire/ -- Perry Baromedical, international leader in Hyperbaric Chamber manufacturing for 40 years, announces the launch of the Sigma Elite, with extended patient data capture capability. The advanced technology of the Sigma Elite is available on each monoplace chamber model currently available (www.perrybaromedical.com) and has a Patent Pending.

The Sigma Elite New "Smart Hyperbaric System" includes:

  • Data Capture Via Computerized System for Each Dive
  • Electronic (EMR) Medical Records Interface (Optional)
  • Individualized Patient Profiles
  • Visual Graphs in Real Time with Date & Time Log
  • Touch Screen Interface

According to Glenn Dennis, President/COO of Perry Baromedical, "the Sigma Elite now provides the ability for our chambers to provide Patient Data interface to EMR systems. This capability is unique and is in response to customer demand."

Standard features of the Sigma Elite Control and EMR System are:

  • Customizable Automated Treatment Protocols
  • Manual Treatments Captured for Future Use
  • Pneumatic Backup Control System
  • Analog Manual Set Point and Rate Set
  • Hard Copy of Treatment
  • Electronic Record of Treatment
  • Programmable Air Breath Alerts
  • Standard Treatment Profiles Pre-installed
  • Windows XPE Embedded Operating System
  • Split Screen Auxiliary Capability
  • Patient Record Dive Review

Perry Baromedical Corporation is dedicated to providing safe, cost effective and technologically advanced Hyperbaric Oxygen Chambers. Expertise and advanced technology along with proprietary manufacturing process and global resources, allow us to produce, ship, install and service the finest Hyperbaric Oxygen Chambers worldwide. Perry Baromedical is the only US hyperbaric chamber manufacturer that builds three acrylic monoplace models, dualplace, and multiplace units including the largest acrylic monoplace chamber in the world. www.perrybaromedical.com or call 1-800-741-4376.

SOURCE Perry Baromedical


'/>"/>
SOURCE Perry Baromedical
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
7. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
8. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
9. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
10. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
11. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2016)... , May 25, 2016 ... H1 2016"market research report that provides an overview ... comparative analysis at various stages, therapeutics assessment by ... administration (RoA) and molecule type, along with latest ... also reviews key players involved in the therapeutic ...
(Date:5/24/2016)... AMSTERDAM , May 24, 2016 ... aplicación médica para ayudar a los médicos a compartir ... los pacientes a escala mundial. Profesionales médicos de Europa, ... ya se han apuntado a la aplicación, que combina ... en un entorno totalmente seguro. Educación   ...
(Date:5/24/2016)...   , Study met both ... superiority in , Excellent plus Good ... of the ascending colon   , ... today announced new positive data from the phase III MORA study ... 2 litre PEG with ascorbate. The study met both primary endpoints ...
Breaking Medicine Technology:
(Date:5/28/2016)... ... ... a year and a half of planning the Multiple Pathways of Recovery Conference , ... Recovery Conference was held May 2 -4, 2016 at the Mystic Marriott Hotel & ... explore the many pathways individuals use to get into and sustain their recovery. Pathways ...
(Date:5/27/2016)... ... 2016 , ... More than a third of American adults are considered obese, ... has received increased attention in recent years, as an article published May ... loss, most people are familiar with the basic requirements of maintaining a healthy diet ...
(Date:5/27/2016)... ... May 27, 2016 , ... Two director-level employees of Horizon Blue Cross ... and Industry (TWIN) 2016 honorees. The award recognizes businesswomen who excel in their ... Boone, Director of the MLTSS (Managed Long-Term Services and Supports) Program at Horizon NJ ...
(Date:5/27/2016)... ... 27, 2016 , ... An influential resource amongst nurses and professionals in the ... on the variety of topics detailing why we appreciate nurses in so many different ... has gone from being in a major recession to one of the hottest growing ...
(Date:5/27/2016)... York, NY (PRWEB) , ... May 27, 2016 , ... ... factors of a stroke, which we as a society can control and change. , ... stroke occurs nearly every 40 seconds within the United States. Plus, with an estimated ...
Breaking Medicine News(10 mins):